Second Line Therapy in Multiple Myeloma: A SEER Medicare Analysis

Authors: LeBlanc, Matthew R., Zhou, Xi, Baggett, Christopher D., Tuchman, Sascha A., Jensen, Christopher E., Lichtman, Eben I., Rubinstein, Samuel M.

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24(9):611-620

Geriatric assessment-guided interventions for older adults with multiple myeloma: A feasibility and acceptability study

Authors: Jensen, Christopher E., Deal, Allison M., Nyrop, Kirsten A., Logan, Maya, Mangieri, Nicholas J., Strayhorn, Martha D., Miller, Jordan, Muss, Hyman B., Lichtman, Eben I., Rubinstein, Samuel M., Tuchman, Sascha A.

Source: In Journal of Geriatric Oncology March 2024 15(2)

Fewer severe infections with tranexamic acid in patients with hematologic malignancies

Authors: Poston, Jacqueline N., Brown, Siobhan P., Ilich, Anton, Ginsburg, Amy Sarah, Herren, Heather, El Kassar, Nahed, Jensen, Christopher E., Triulzi, Darrell J., Key, Nigel S., May, Susanne, Gernsheimer, Terry B.

Source: In Research and Practice in Thrombosis and Haemostasis February 2024 8(2)

SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions

Authors: Jensen, Christopher E., Stephens, Deborah M.

Source: In Clinical Lymphoma, Myeloma and Leukemia July 2024

Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma

Authors: Yusuf, Abdel Rahem S., Heiling, Hillary M., Deal, Allison M., Jensen, Christopher E., Mangieri, Nicholas J., Nyrop, Kirsten A., Lichtman, Eben I., Rubinstein, Samuel M., Grant, Shakira J., Wood, William A., Tuchman, Sascha A., Nakamura, Zev M.

Source: In Clinical Lymphoma, Myeloma and Leukemia December 2022 22(12):920-927

Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia

Authors: Jensen, Christopher E., Montgomery, Nathan D., Galeotti, Jonathan, Foster, Matthew C., Zeidner, Joshua F.

Source: Journal of cellular and molecular medicine. 26(24):6079-6082

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186843031.0x000001&indx=1&recIds=ETOCvdc_100186843031.0x000001

Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders

Authors: Nakamura, Zev M., Vohra, Sanah N., Jensen, Christopher E., Nyrop, Kirsten A., Deal, Allison M., Heiling, Hillary M., Mangieri, Nicholas J., Grant, Shakira J., Lichtman, Eben I., Rubinstein, Samuel M., Wood, William A., Muss, Hyman B., Tuchman, Sascha A.

Source: Journal of geriatric oncology. 13(7):987-996

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173026325.0x000001&indx=1&recIds=ETOCvdc_100173026325.0x000001

Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status

Authors: Jensen, Christopher E., Vohra, Sanah N., Nyrop, Kirsten A., Deal, Allison M., Muss, Hyman B., Lichtman, Eben I., Rubinstein, Samuel M., Wood, William A., Mangieri, Nicholas J., Jamison, Lee, Grant, Shakira J., Tuchman, Sascha A.

Source: Journal of geriatric oncology. 13(2):182-189

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100156115844.0x000001&indx=1&recIds=ETOCvdc_100156115844.0x000001

Real-World Effectiveness of Frontline Treatments Among Patients with Chronic Lymphocytic Leukemia: Results from ConcertAI.

Authors: Roeker, Lindsey E., Burke, John M., Rhodes, Joanna M., Emechebe, Nnadozie, Jawaid, Dureshahwar, Manzoor, Beenish S., Jensen, Christopher E., Ryland, Lindsay, Liu, Yangyang, Marx, Steve E., Sinai, Wendy, Roser, Jordan, Shadman, Mazyar

Source: Cancers; Mar2025, Vol. 17 Issue 5, p799, 15p

SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions.

Authors: Jensen, Christopher E., Stephens, Deborah M.

Source: Clinical Lymphoma, Myeloma & Leukemia; Mar2025, Vol. 25 Issue 3, p135-141, 7p

Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy.

Authors: Richardson, Daniel R., Zhou, Xi, Reeder-Hayes, Katherine, Jensen, Christopher E., Islam, Jessica, Loh, Kah Poh, Gupta, Arjun, Basch, Ethan, Bennett, Antonia V., Bridges, John F. P., Wheeler, Stephanie B., Wood, William A., Baggett, Christopher D., Lund, Jennifer L.

Source: JAMA Oncology; Aug2024, Vol. 10 Issue 8, p1038-1046, 9p

The Triage of Older Adults with Physiologic Markers of Serious Injury Using a State-Wide Prehospital Plan

Authors: Meyers, Matthew H., Wei, Trent L., Cyr, Julianne M., Hunold, Thomas M., Shofer, Frances S., Cowden, Christopher S., Moss, Chailee F., Jensen, Christopher E., Platts-Mills, Timothy F., Brice, Jane H.

Source: Prehospital and disaster medicine. 34(5):497-505

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN621765485&indx=1&recIds=ETOCRN621765485

Immune checkpoint inhibitors for hepatocellular carcinoma

Authors: Jensen, Christopher E, Loaiza-Bonilla, Arturo, Bonilla-Reyes, Paula A

Source: Hepatic oncology. 3(3):201-211

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139384831.0x000001&indx=1&recIds=ETOCvdc_100139384831.0x000001

CLL-495 Treatment Characteristics and Outcomes of Patients With Chronic/Small Lymphocytic Leukemia (CLL) Treated With Venetoclax and Bruton Tyrosine Kinase Inhibitor (BTKi) Combination Therapies

Authors: Tuncer, Hande H., Ghosh, Nilanjan, Fleury, Isabelle, Leslie, Lori A., Manzoor, Beenish S., Lamanna, Nicole, Eyre, Toby A., Hill, Brian T., Brown, Jennifer R., Sinai, Wendy, Coombs, Catherine C., Ujjani, Chaitra, Roeker, Lindsey E., Emechebe, Nnadozie, Barr, Paul M., Davids, Matthew S., Martinez-Calle, Nicolas, Rhodes, Joanna M., Lansigan, Frederick, Pearson, Laurie, Choi, Yun, Schuster, Stephen J., Skarbnik, Alan P., Fakhri, Bita, Coyle, Michael, Stephens, Deborah M., Thompson, Meghan C., Jensen, Christopher E., Marx, Steven E., Jawaid, Dureshahwar, Schuh, Anna, Pivneva, Irina, Watson, Talissa, Guerin, Annie, Shadman, Mazyar

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S357-S358

Treatment Characteristics and Outcomes of Patients With Chronic/Small Lymphocytic Leukemia (CLL) Treated With Venetoclax and Bruton Tyrosine Kinase Inhibitor (BTKi) Combination Therapies

Authors: Tuncer, Hande H., Ghosh, Nilanjan, Fleury, Isabelle, Leslie, Lori A., Manzoor, Beenish S., Lamanna, Nicole, Eyre, Toby A., Hill, Brian T., Brown, Jennifer R., Sinai, Wendy, Coombs, Catherine C., Ujjani, Chaitra, Roeker, Lindsey E., Emechebe, Nnadozie, Barr, Paul M., Davids, Matthew S., Martinez-Calle, Nicolas, Rhodes, Joanna M., Lansigan, Frederick, Pearson, Laurie, Choi, Yun, Schuster, Stephen J., Skarbnik, Alan P., Fakhri, Bita, Coyle, Michael, Stephens, Deborah M., Thompson, Meghan C., Jensen, Christopher E., Marx, Steven E., Jawaid, Dureshahwar, Schuh, Anna, Pivneva, Irina, Watson, Talissa, Guerin, Annie, Shadman, Mazyar

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S183-S183

Treatment Effectiveness with Venetoclax-Based Therapy after Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

Authors: Ghosh, Nilanjan, Lamanna, Nicole, Eyre, Toby A., Coombs, Catherine C, Manzoor, Beenish S, Brown, Jennifer R., Tuncer, Hande H., Ujjani, Chaitra S, Leslie, Lori A, Roeker, Lindsey E., Davids, Matthew S, Rhodes, Joanna M., Skarbnik, Alan, Emechebe, Nnadozie, Fleury, Isabelle, Hill, Brian T., Fox, Christopher P., Barr, Paul M., Jawaid, Dureshahwar, Sinai, Wendy J, Pearson, Laurie K, Lansigan, Frederick, Choi, Yun, Jensen, Christopher E., Schuster, Stephen J., Kennard, Kaitlin, Pivneva, Irina, Watson, Talissa, Guerin, Annie, Shadman, Mazyar

Source: In Blood 2 November 2023 142 Supplement 1:1908-1908

A Phase 2 Study of Minimal Residual Disease (MRD)-Adapted Front Line Venetoclax and Obinutuzumab in Fit Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Obinutuzumab on Tumor Lysis Syndrome (TLS) Risk and Safety of Outpatient Venetoclax Dose Escalation

Authors: Roeker, Lindsey E., Zelenetz, Andrew D., Park, Jae H., Derkach, Andriy, Geyer, Mark Blaine, Islam, Prioty, Falchi, Lorenzo, Palomba, Maria Lia, Kumar, Anita, Salles, Gilles, Lue, Jennifer Kimberly, Goldberg, Aaron D., Fakhri, Bita, Coombs, Catherine C., Falco, Victoria, Panton, Gail, Tyznar, Dianna, Soni, Dhara, Nogan, Lauren, Lebowitz, Sonia, Blesie, Katherine, Shah, Monica, Court, Sarah, Jensen, Christopher E., Mato, Anthony R., Thompson, Meghan C.

Source: In Blood 2 November 2023 142 Supplement 1:4657-4657

Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life.

Authors: Jensen, Christopher E, Vohra, Sanah N, Nyrop, Kirsten A, Deal, Allison M, LeBlanc, Matthew R, Grant, Shakira J, Muss, Hyman B, Lichtman, Eben I, Rubinstein, Samuel M, Wood, William A, Mangieri, Nicholas J, Jamison, Lee, Tuchman, Sascha A

Source: Oncologist; Aug2022, Vol. 27 Issue 8, p694-702, 9p, 5 Charts, 2 Graphs

Subject Terms: AMYLOIDOSIS, FUNCTIONAL status, REGRESSION analysis, GERIATRIC assessment, FUNCTIONAL assessment, QUALITY of life, QUESTIONNAIRES, DESCRIPTIVE statistics, MULTIPLE myeloma, EARLY diagnosis, SYMPTOMS, ADULTS

Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis.

Authors: Jensen, Christopher E., Byku, Mirnela, Hladik, Gerald A., Jain, Koyal, Traub, Rebecca E., Tuchman, Sascha A.

Source: Frontiers in Oncology; 6/23/2022, Vol. 12, p1-10, 10p

Subject Terms: IMMUNOGLOBULIN light chains, CARDIAC amyloidosis, AMYLOIDOSIS, PLASMA cell diseases, SYMPTOMS, NEURAL development

Functional Status and Mortality Among Older Adults with Multiple Myeloma

Authors: Jensen, Christopher E., Kuo, Tzy-Mey ^*, Leblanc, Matthew ^*, Baggett, Chris D ^*, Zhou, Xi ^*, Reeder-Hayes, Katherine E ^*, Lund, Jennifer L ^*

Source: In Blood 15 November 2022 140 Supplement 1:5221-5222